T. Tanaka et al., ENHANCEMENT OF ANTIGEN-INDUCED T-CELL PROLIFERATION BY SOLUBLE CD26 DIPEPTIDYL PEPTIDASE-IV, Proceedings of the National Academy of Sciences of the United Statesof America, 91(8), 1994, pp. 3082-3086
The addition of a soluble recombinant CD26 (sCD26) enhanced proliferat
ion of peripheral blood lymphocytes induced by the recall antigen teta
nus toxoid. sCD26 itself did not provide a mitogenic signal and did no
t augment the proliferative response of T cells to other mitogenic sti
muli such as phytohemagglutinin and anti-CD3. Dipeptidyl peptidase IV-
negative sCD26 did not have this enhancement effect, implying a requir
ement for enzyme activity. It was found that there exists a large vari
ation in the levels of human plasma sCD26/dipeptidyl peptidase IV in v
ivo which may regulate T-cell activity. Peripheral blood lymphocytes f
rom individuals whose plasma sCD26 was high and responded strongly to
tetanus toxoid stimulation were insensitive to the enhancing effects o
f exogenously added sCD26. This suggests that plasma sCD26 had modulat
ed the responsiveness of T cells of these individuals in vivo and that
the endogenous plasma sCD26 regulates immune responses by allowing an
tigen-specific T cells to exert a maximal response to their specific a
ntigen.